InvestorsHub Logo
Followers 26
Posts 4067
Boards Moderated 0
Alias Born 12/26/2018

Re: roiresearch post# 307660

Thursday, 07/02/2020 12:25:28 PM

Thursday, July 02, 2020 12:25:28 PM

Post# of 402726
Yep. I've been invested here over five years and read all the filings and PRs very closely. I could probably recite to you every trial we have done, with the arms, and the results of each with reasonable accurately from memory.

Nothing in the snippets you posted addressed the question. I hope you read them carefully. At a glance you might miss a couple words and be under the impression that we have conducted phase 2 trials for COVID-19.


The latest PR:
Brilacidin is one of the few drugs targeting COVID-19 that has been tested in human trials (a total of 8) for other clinical indications, providing an established safety and efficacy database on over 460 subjects, thereby potentially enabling it to rapidly help address the novel coronavirus crisis.

From a May PR:
Brilacidin is one of the few drugs targeting COVID-19 that has been tested in Phase 2 human trials for other clinical indications, providing an established safety and efficacy profile, thereby potentially enabling it to rapidly help address the worldwide coronavirus crisis.


My question was with regard to a statement that Brilacidin can kill everything in reference to various viruses. We have seen it work in vitro but we don't have any human data with regard to anti-viral efficacy. We don't know if it will be efficacious in humans at all let alone at a safe dosage. The in vitro tests combined with the previous ABSSSI safety profile suggest there is a reasonable chance that it will.

Go IPIX!

PS How'd I do Loan?

Make IPIX Great Again!

Because now it looks like we were absolute geniuses for purchasing our antibiotic from bankruptcy court a year ago for $5 million." - LE

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IPIX News